Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Chim Acta ; 413(19-20): 1459-65, 2012 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-22687649

RESUMO

BACKGROUND: Catecholamines and their metabolites, metanephrines, are produced excessively in pheochromocytoma tumors of the chromaffin cells. Increased concentrations of these compounds produce symptoms and allow for clinical evaluation of disease. Historically, screening for such tumors by determination of catecholamines and metabolites in urine yielded false negative results in individuals with a genetic predisposition for the disease and those with paroxysmal hypertension. Analysis of metanephrines in plasma, however, is of decisive diagnostic importance. This test exhibits high sensitivity and specificity for the analytes produced by tumors. METHODS: Plasma proteins are removed by solid phase extraction. Chromatographic isolation of the analytes and stable isotope internal standards is achieved by elution on a HILIC column connected to a UPLC MS/MS system. Metanephrines are measured using multiple reaction monitoring with an electrospray source operating in positive ion mode. RESULTS: The method was validated for linearity, limit of quantification, accuracy, and precision. The method was accurate and correlated well to a comparison HPLC method. Potential interferences were evaluated. CONCLUSIONS: Results from this LC-MS/MS assay enable clinical diagnosis of pheochromocytoma and aid in monitoring treatment outcomes.


Assuntos
Neoplasias das Glândulas Suprarrenais/sangue , Metanefrina/análogos & derivados , Metanefrina/sangue , Feocromocitoma/sangue , Neoplasias das Glândulas Suprarrenais/diagnóstico , Cromatografia Líquida , Humanos , Limite de Detecção , Feocromocitoma/diagnóstico , Valores de Referência , Extração em Fase Sólida , Espectrometria de Massas em Tandem
2.
Rapid Commun Mass Spectrom ; 21(6): 903-10, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17315275

RESUMO

Dirhenium adducts of purine dinucleotides were identified by mass spectrometry. In consecutive studies, Re(2)(O(2)C(2)H(3))(2)Cl(4) . 2H(2)O was reacted with 2'-deoxyguanylyl(3'-->5')-2'-deoxyguanosine (dGpG) and 2'-deoxyadenylyl(3'-->5')-2'-deoxyguanosine (dApG) in H(2)O or D(2)O. These reactions were monitored to identify novel dinuclear rhenium:dinucleotide complexes as confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS), electrospray ionization mass spectrometry (ESI-MS) and collision-induced dissociation tandem mass spectrometry (CID MS/MS) experiments. However, the most abundant adducts detected by ES-MS were dirhenium:nucleotide species. Of these, guanine-containing ions were observed with highest ion counts suggesting a preference for guanine coordination. Dimetal adducts showed coordination of the purine bases and common metalated fragments were observed for both dGpG and dApG reactions.


Assuntos
Cromatografia Líquida/métodos , Espectrometria de Massas/métodos , Modelos Químicos , Modelos Moleculares , Nucleotídeos de Purina/química , Rênio/química , Substâncias Macromoleculares/química , Conformação Molecular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...